Throughout the drug development process and lifecycle management, digital content is “created” and “consumed” by various cross-functional departments like regulatory, safety, medical, or clinical. The absence of a homogenous platform often leads to delay in bringing the right information to the right person at the right time. Intelligent content authoring (ICA) involves creation of a fully indexed knowledge base derived from source documents, and helps ensure faster time-to-agency, faster time-to-market, and exceptionally high gains in productivity and effi¬ciency in developing medical content.